Beta Drugs IPO vs IRIS Business Services IPO

Comparison between Beta Drugs IPO and IRIS Business Services IPO.

IPO Details

Beta Drugs IPO is a SME Fixed Price IPO proposed to list at NSE SME while IRIS Business Services IPO is a SME Fixed Price proposed to list at BSE SME.

Issue Size and Price

The total issue size of Beta Drugs IPO is up to ₹18.41 Cr whereas the issue size of the IRIS Business Services IPO is up to ₹15.18 Cr. The final issue price of Beta Drugs IPO is ₹85.00 per share and of IRIS Business Services IPO is ₹32.00 per share.

 Beta Drugs IPOIRIS Business Services IPO
Face Value₹10 per share₹10 per share
Issue Price (Final)₹85.00 per share₹32.00 per share
Discount (Retail)₹0.00 per share₹0.00 per share
Market Lot Size1600 shares4000 shares
Fresh Issue Size21,66,400 shares47,44,000 shares
Fresh Issue Size (Amount)up to ₹18.41 Crup to ₹15.18 Cr
OFS Issue Size0 shares0 shares
OFS Issue Size (Amount)up to ₹0.00 Crup to ₹0.00 Cr
Issue Size Total21,66,400 shares47,44,000 shares
Issue Size Total (Amount)up to ₹18.41 Crup to ₹15.18 Cr

IPO Timetable

Beta Drugs IPO opens on Sep 29, 2017, while IRIS Business Services IPO opens on Sep 29, 2017. The closing date of Beta Drugs IPO and IRIS Business Services IPO is Oct 04, 2017, and Oct 04, 2017, respectively.

 Beta Drugs IPOIRIS Business Services IPO
Issue OpenSep 29, 2017Sep 29, 2017
Issue CloseOct 04, 2017Oct 04, 2017
Basis Of Allotment (Tentative)Oct 10, 2017Oct 09, 2017
Listing date (Tentative)Oct 12, 2017Oct 11, 2017

Financials & KPIs

Beta Drugs IPO P/E ratio is , as compared to IRIS Business Services IPO P/E ratio of .

 Beta Drugs IPOIRIS Business Services IPO
Financials

Company Financials (Restated)

Period Ended31 Mar 201731 Mar 201631 Mar 2015
Assets24.5415.208.01
Total Income41.6826.390.26
Profit After Tax5.181.130.11
NET Worth7.382.201.07
Reserves and Surplus6.371.190.06
Total Borrowing7.527.754.37
Amount in ₹ Crore

Company Financials (Restated Standalone)

Period Ended31 Mar 201731 Mar 201631 Mar 2015
Assets60.4963.9863.26
Total Income27.3432.7755.72
Profit After Tax-9.04-6.713.38
NET Worth19.9229.9335.68
Reserves and Surplus12.9922.9928.74
Total Borrowing15.2615.426.73
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue)93.78%53.46%
Promoter Shareholding (Post-Issue)68.89%39.29%
Market Cap₹73.52 Cr.₹60.41 Cr.

Shares Offered

In the Beta Drugs IPO Retail Individual Investors (RII) are offered 10,83,200 shares while in IRIS Business Services IPO retail investors are offered 10,83,200 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Beta Drugs IPO and 0 shares in IRIS Business Services IPO.

 Beta Drugs IPOIRIS Business Services IPO
Anchor Investor Reservation0 shares0 shares
Market Maker Reservation1,29,600 shares2,60,000 shares
QIB0 shares0 shares
NII10,83,200 shares23,72,000 shares
RII10,83,200 shares23,72,000 shares
Employee0 shares0 shares
Total21,66,400 shares47,44,000 shares

Bids Received (Subscription)

Beta Drugs IPO subscribed 18.97x in total, whereas IRIS Business Services IPO subscribed 2.39x.

 Beta Drugs IPOIRIS Business Services IPO
NII (times)29.93x4.21x
RII (times)8.00x0.56x
Total (times)18.97x2.39x

Compare with others

Compare:

Beta Drugs IPO Vs IRIS Business Services IPO